Company Overview and News

Snap-On's stock climbs 2.3% premarket after Q1 results

19h marketwatch
Snap-on Inc. SNA said Thursday that first-quarter net income rose 15%, in part due to the tax overhaul in the U.S. The Wisconsin-based maker of automotive tools, diagnostic equipment, and software earned a quarterly profit of $163 million, or $2.82 a share, compared with $141.6 million, or $2.39 a share, for the same period a year earlier.
Upvote Downvote

Cenovus to hold conference call and webcast on first quarter 2018 results

2018-04-18 globenewswire
CALGARY, Alberta, April 18, 2018 (GLOBE NEWSWIRE) -- Cenovus Energy Inc. (TSX:CVE) (NYSE:CVE) will release its first quarter 2018 results on Wednesday, April 25, 2018. The news release will provide consolidated first quarter operating and financial information. Financial statements will be available on the company’s website,
Upvote Downvote

Shale oil has a refining problem and Morgan Stanley smells opportunity

2018-04-17 cnbc
Surging U.S. oil supplies may soon struggle to find a buyer, and Morgan Stanley believes that could create winners in the stock and commodity markets.
Upvote Downvote

Cenovus Energy: Cash Flow Doubles While Mr. Market Dumps The Stock

2018-04-09 seekingalpha
Yet the stock tanked several times last year on market doubts about Canadian oil industry challenges and the acquisition.
Upvote Downvote

5 things at play in Alberta and B.C.'s fight over the Kinder Morgan pipeline

The company announced Sunday that it is suspending non-essential activities and related spending for the Trans Mountain pipeline expansion, casting a cloud over the future of the $7.4-billion project.
Upvote Downvote

These Integrated Energy Stocks Are Gaining this Week

Continuing with the biggest movers in the energy sector, we’ll now look at the top gainers from the US integrated energy sector for the week starting April 2.
Upvote Downvote

CANADA STOCKS-TSX extends gains on Bank of Montreal's optimism over NAFTA talks

2018-04-05 reuters
April 5 (Reuters) - Canada’s main stock index rose more than 1 percent on Thursday, led by a surge in energy stocks and rising confidence that NAFTA talks will result in a positive outcome.
Upvote Downvote

UPDATE 3-Cenovus ropes in oil industry veteran from Husky Energy as CFO

2018-04-05 reuters
April 5 (Reuters) - Canadian oil and gas producer Cenovus Energy Inc said on Thursday it named Jon McKenzie chief financial officer, bringing in an industry veteran who most recently helped rival Husky Energy Inc rein in costs and strengthen its finances.
Upvote Downvote

CVE / Cenovus Energy Inc. 6-K (Current Report of Foreign Issuer)

Upvote Downvote

CVE / Cenovus Energy Inc. 6-K (Current Report of Foreign Issuer)

Upvote Downvote

Spartan Energy Hits The Cheap Button Again

2018-04-04 seekingalpha
The stock price is roughly 5 times the funds flow when considering the exchange rate of the Canadian Dollar.
Upvote Downvote

MEG Energy: Asset Sale Paves Way For Growth

2018-03-28 seekingalpha
Higher financial flexibility after asset sale and the company is fully financed for the next 24 months.
Upvote Downvote

Canadian Railways In A Catch-22 Over Crude Shipment

2018-03-27 rigzone
March 27 (Reuters) - Canadian railway operators see a lucrative opportunity to transport more crude oil to the United States as a rise in output force producers to find new routes to its southern neighbor.
Upvote Downvote

Canada’s crude-by-rail terminals sit idle amid locomotive shortage as demand for oil grows

2018-03-27 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to:
Upvote Downvote

Canadian railways in a catch-22 over crude shipment

2018-03-27 reuters
(Reuters) - Canadian railway operators see a lucrative opportunity to transport more crude oil to the United States as a rise in output force producers to find new routes to its southern neighbor.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 15135U109